Crime
NEW YORK — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the struggling...
Hi, what are you looking for?
NEW YORK — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the struggling...
Emily Bloch | (TNS) The Philadelphia Inquirer 23andMe is facing scrutiny, with some experts calling it the beginning of the end for the popular genetic...